Operational Optimizations Will Drive Future Profitability In Retail And Pharmacy

Published
08 Aug 24
Updated
20 Aug 25
AnalystConsensusTarget's Fair Value
US$11.93
1.2% overvalued intrinsic discount
20 Aug
US$12.07
Loading
1Y
17.2%
7D
0.9%

Author's Valuation

US$11.9

1.2% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on07 May 25
Fair value Decreased 2.95%

Shared on30 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on16 Apr 25
Fair value Increased 0.081%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 1.21%

AnalystConsensusTarget has decreased profit margin from 0.2% to 0.1% and increased future PE multiple from 45.4x to 73.7x.

Shared on02 Apr 25
Fair value Increased 0.081%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Increased 4.13%

AnalystConsensusTarget has increased profit margin from 0.1% to 0.2% and decreased future PE multiple from 74.9x to 45.4x.

Shared on10 Mar 25
Fair value Decreased 3.92%